Financial Data and Key Metrics Changes - For the third quarter of 2023, the company reported net investment income of $0.37 per share, a 16% increase year-over-year, driven by portfolio growth and rising reference rates [26][27] - The net asset value per share increased to $18.06 from $17.98 at the end of the previous quarter [26][33] - Gross investment income totaled $59.6 million, up from $56.3 million in the prior quarter, while net expenses rose to $36.3 million from $33.7 million [14][15] Business Line Data and Key Metrics Changes - The comprehensive portfolio consisted of approximately $3.1 billion in senior secured loans across 790 borrowers, with 99.2% of the portfolio in senior secured loans [38] - The weighted average yield on the cash flow portfolio was reported at 11.8%, with a weighted average asset level yield of 15.3%, up from 14.6% in the previous quarter [20][21] - In the sponsor finance cash flow business, the company originated $115 million in loans during the third quarter, with repayments of $34 million [40] Market Data and Key Metrics Changes - The company noted an increase in M&A activity and a resilient U.S. economy despite geopolitical tensions and inflationary pressures [7][8] - The life sciences sector has been impacted by a decline in investment valuations, but the company remains optimistic about financing quality borrowers with resilient cash flows [27][64] Company Strategy and Development Direction - The company aims to maintain a defensive approach to asset selection to achieve strong performance amid economic uncertainties [8][17] - SLR Investment Corp is focusing on expanding its infrastructure and origination capabilities to capitalize on attractive investment opportunities [31][32] - The company plans to leverage its diversified platform across sponsor and specialty finance strategies to generate attractive returns while protecting capital [28][30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of the U.S. economy and the potential for increased M&A activity, which could benefit middle-market lenders [7][47] - The company anticipates a favorable investment environment with ample available capital to capitalize on opportunities [32][68] - Management highlighted the importance of maintaining liquidity and free cash flow to navigate potential interest rate increases [75][76] Other Important Information - The company declared a quarterly distribution of $0.41 per share, payable on December 28, 2023 [36] - The company has approximately $1.2 billion of debt outstanding, with a leverage ratio of 1.21 times net debt to equity [13] Q&A Session Summary Question: Characteristics of investments in SSLP - The company explained that the SSLP primarily consists of migrating lower-yielding cash flow assets from the merged entity, with some direct cash flow loans being originated [72] Question: Issues in the life sciences segment - Management noted that early-stage companies are facing capital raising challenges due to declining valuations, but their portfolio companies are insulated due to having revenues and cash runway [73][74] Question: Current interest rate sensitivity - Management stated that they are comfortable with their portfolio's ability to handle interest rate increases of 50 to 100 basis points based on stress tests [75][76] Question: Status of the joint venture and facility - The company confirmed expectations to reach $230 million to $250 million in commitments by year-end, with a maximum of about $300 million as they complete the ramp [78] Question: Asset-based loans yield reconciliation - Management discussed the complexities of the asset-based loan portfolio and the expectation to improve returns as they ramp up the portfolio [81][84] Question: Transition back to quarterly dividends - Management explained that returning to quarterly dividends was a strategic decision to save costs and align with industry practices [87]

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarter Ended September 30, 2023 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Commission File Number: 814-00754 SLR INVESTMENT CORP. (Exact name of registrant as specified in its charter) Maryland 26-1381340 (State of Incorporation) (I.R.S. Employer 500 Park Avenue Ne ...

SLR Investment Corp (NASDAQ:SLRC) Q2 2023 Results Conference Call August 9, 2023 10:00 AM ET Company Participants Michael Gross - Chairman, President and Co-CEO Shiraz Kajee - CFO, Treasurer and Secretary Bruce Spohler - COO, Co-CEO and Interested Director Conference Call Participants Sean-Paul Adams - Raymond James Paul Johnson - KBW Casey Alexander - Compass Point Operator Good day, everyone, and welcome to today's SLR Investment Corporation Second Quarter Earnings Call. At this time, all participants are ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarter Ended June 30, 2023 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 814-00754 SLR INVESTMENT CORP. (Exact name of registrant as specified in its charter) (State of Incorporation) (I.R.S. Employer 500 Park Avenue New York, N.Y. 10022 (Addre ...

Financial Data and Key Metrics Changes - For the three months ended March 31, 2023, gross investment income totaled $53.5 million, a slight decrease from $54.1 million for the three months ended December 31, 2022 [1] - Net investment income for the same period was $22.1 million or $0.41 per average share, compared to $22.5 million or $0.41 per average share for the previous quarter [29] - The net asset value at March 31, 2023, was approximately $984 million or $18.04 per share, down from $1 billion or $18.33 per share at December 31, 2022 [26] Business Line Data and Key Metrics Changes - The asset-based loan (ABL) portfolio totaled $1 billion, representing one-third of the comprehensive portfolio, with a weighted average asset level yield of 13.6% [10] - The equipment finance portfolio totaled $938 million, representing 32% of the total portfolio, with a weighted average asset level yield just under 10% [13] - The life science segment's portfolio totaled $323 million across 14 borrowers, contributing just under 24% of gross investment income for the quarter [17] Market Data and Key Metrics Changes - Yields in the private debt market have increased, with current yields of 12% to 13% compared to 7% to 9% a year ago [2] - The weighted average yield on the entire cash flow portfolio was 11.8%, up from 11.2% in the prior quarter [6] - The company has seen a strong pipeline with an average yield of over 12.5% and an LTV of 35% [3] Company Strategy and Development Direction - The company is focusing on defensive sectors such as healthcare services and insurance brokerage, with a portfolio that has strong credit metrics [5] - The strategy includes expanding the ABL segment, which has historically outperformed during market volatility [7] - The company plans to leverage its strong capital position to capitalize on attractive investment opportunities arising from regional banking sector disruptions [19][21] Management's Comments on Operating Environment and Future Outlook - Management noted that the current investment environment is favorable, particularly for specialty finance businesses benefiting from regional banking turmoil [78] - The company expects net portfolio growth throughout the year due to limited repayment activity and a strong investment pipeline [22] - Management expressed confidence in the portfolio's ability to perform well through economic downturns, enabling the company to capitalize on market dislocations [19] Other Important Information - The company waived approximately $110,000 of related incentive fees during the quarter [28] - The Board declared a monthly distribution of $0.136667 per share, payable on June 1, 2023 [31] - The company has significant available capital to fund future portfolio growth while remaining within its target leverage range of 0.9 to 1.25 times net debt to equity [27] Q&A Session Summary Question: Can you elaborate on the scaling of the SSLP and its impact on NII? - Management confirmed the target to grow the SSLP to $250 million by year-end, with current assets at about $150 million [66] Question: How do you expect to increase ROE over time? - Management indicated that they expect to increase ROE through significant capital deployment at attractive net yields [70] Question: Are there any systemic issues across the portfolio? - Management clarified that the write-down of one investment was idiosyncratic and not indicative of broader portfolio stress [100]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarter Ended March 31, 2023 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 814-00754 SLR INVESTMENT CORP. (Exact name of registrant as specified in its charter) (State of Incorporation) (I.R.S. Employer 500 Park Avenue New York, N.Y. 10022 (Addr ...

Financial Data and Key Metrics Changes - For Q4 2022, the company reported net investment income of $0.41 per share, fully covering distributions, an increase from $0.37 per share in Q3 2022 [10][35] - Net asset value per share decreased slightly to $18.33 from $18.37 at the end of Q3 2022 [11][32] - Gross investment income rose to $54.1 million from $47.6 million in the previous quarter, while net expenses increased to $31.6 million from $27.5 million [34] Business Line Data and Key Metrics Changes - The comprehensive portfolio at year-end was approximately $2.9 billion, with 99.8% in senior secured loans, and 98.6% in first lien loans [39][40] - The weighted average asset level yield increased to 12.2% from 11.3% in the previous quarter [42] - The Sponsor Finance segment originated $58 million in new loans, with repayments of $118 million, resulting in a portfolio of $643 million [48] - The ABL segment saw a portfolio total of $1 billion, with an average asset level yield of 14.1%, up from 12.3% [53] - The Equipment Finance portfolio totaled $900 million, with a weighted average asset level yield of 10.7% [56] - The Life Science segment had a portfolio of $322 million, contributing 20% of gross investment income for Q4 [60] Market Data and Key Metrics Changes - The current market conditions for new investments are described as the most attractive in several years, with a significant increase in yields on private loans [15][46] - The company has over $650 million in available capital to capitalize on investment opportunities [28] Company Strategy and Development Direction - The company plans to continue growing its portfolio, expecting 2023 to be an attractive vintage for both cash flow and specialty finance loans [21][65] - The investment adviser secured $3.8 billion in additional capital, enhancing the company's competitive sourcing advantage [24] - The company emphasizes a conservative underwriting approach, focusing on first lien cash flow loans and asset-based loans to mitigate risks during economic volatility [64] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the credit quality of the portfolio, supported by a comprehensive stress test [13][89] - The company anticipates further growth in net investment income per share in 2023, driven by deploying available capital into higher-yielding assets [21][65] - Management noted that borrowers are increasingly turning to asset-based lending for working capital and liquidity management during uncertain economic times [25] Other Important Information - The company repurchased approximately $3 million of shares at an average price of $13.98 during Q4 [30] - The company has a strong funding profile, with half of its $1.1 billion funded debt comprised of senior unsecured fixed-rate notes at a weighted average interest rate of 3.9% [26] Q&A Session Summary Question: How long does it take for the portfolio to turn over and what yields are being obtained? - The portfolio has a high churn rate, and new assets are being deployed above the current yield of 10.7% [68] Question: Does the equipment financing portfolio include loans backed by crypto mining machines? - No, the equipment financing portfolio does not include such loans [72] Question: Which of the four sectors looks relatively more attractive for growth? - ABL is expected to outpace other segments due to current market conditions, with steady activity in Sponsor Finance and Life Science segments [76][78] Question: What is the average life of the assets in the ABL portfolio? - The average duration of loans is typically 5 years, with an average duration closer to 2 years [110] Question: What is the source of funds for the repayment of the $75 million unsecured notes? - The repayment was funded through a combination of pre-refinanced capital and the revolving credit line [92] Question: Will the stock repurchase program be extended beyond May? - The program is likely to be extended, allowing flexibility to take advantage of market conditions [96]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 814-00754 SLR INVESTMENT CORP. (Exact name of registrant as specified in its charter) (State of Incorporation) (I.R.S. Employer 5 ...

SLR Investment Corporation (NASDAQ:SLRC) Q3 2022 Earnings Conference Call November 3, 2022 10:00 AM ET Company Participants Michael Gross - Chairman, President & Co-CEO Richard Peteka - Treasurer, Secretary & CFO Bruce Spohler - COO, Co-CEO & Interested Director Conference Call Participants Sean Adams - Raymond James Melissa Wedel - JPMorgan Chase & Co. Paul Johnson - KBW Operator Good day, everyone, and welcome to the Q3 2022 SLR Investment Corp. Earnings Call. [Operator Instructions]. Please note, this c ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarter Ended September 30, 2022 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 814-00754 SLR INVESTMENT CORP. (Exact name of registrant as specified in its charter) Maryland 26-1381340 (State of Incorporation) (I.R.S. Employer 500 Park Avenue Ne ...